Common breast cancer mutation could be vulnerable to drug combination

Common breast cancer mutation could be vulnerable to drug combination 12/21/2016 07:04 PM EST Breast cancer cells that carry a certain gene mutation can be induced to die using a combination of an existing targeted therapy along with an investigational molecule tested by Duke University Cancer Institute researchers. Full story at https://medschool.duke.edu/about-us/news-and-communications/med-school-blog/common-breast-cancer-mutation-could-be-vulnerable-drug-combination Source Duke University Medical Center This is an NSF News From the Field item. This e-mail update was generated automatically based on your subscription to the category listed above. Some updates may belong to more than one category, resulting in duplicate messages.   Subscriber Services: Manage Preferences  |  Unsubscribe  |  Help  |  Contact NSF   Follow NSF:  This email was sent to mantiskhiralla@gmail.com using GovDelivery, on behalf of: National Science Foundation Update · 4201 Wilson Boulevard · Arlington, VA 22230 · 703-292-5111